A retrospective study describing the effective exchange of total blood plasma for disease control in the exacerbation of serpiginous choroiditis

Author:

Katayama Yuri1,Katagiri Daisuke1ORCID,Harada Takuya2,Terakawa Kanako1,Shimada Keiki1,Sakamoto Emi1,Niikura Takahito1,Suzuki Minami1,Yoshizaki Yuki1,Nunose Naoto3,Sato Motohiko3,Yashiro Shigeko4,Kaneko Hiroshi2,Takano Hideki1

Affiliation:

1. Department of Nephrology National Center for Global Health and Medicine Tokyo Japan

2. Division of Rheumatic Diseases National Center for Global Health and Medicine Tokyo Japan

3. Medical Equipment Management Office National Center for Global Health and Medicine Tokyo Japan

4. Department of Ophthalmology National Center for Global Health and Medicine Tokyo Japan

Abstract

AbstractIntroductionSerpiginous choroiditis presents with large yellow‐white exudative lesions that occur near the optic nerve papillae, that progresses slowly with repeated relapses and cures. Although infection and autoimmunity have been implicated, the cause is unknown.MethodsA man was diagnosed with serpiginous choroiditis on clinical and other examinations. He started treatment with oral corticosteroids, cyclophosphamide, adalimumab, azathioprine, rituximab, and mycophenolate mofetil. Only the steroids and cyclophosphamide had a therapeutic effect. Plasma exchange was initiated, and the lesions quickly resolved.ResultsDisease control has been maintained by plasma exchange and cyclophosphamide during flare‐ups in the fall and winter, suggesting that plasma exchange is effective in the treatment of serpiginous choroiditis.ConclusionThe reproducible response with each recurrence suggests a strong association between the disease and autoimmunity. Furthermore, that some, as yet unknown, autoantibodies are involved in the pathogenesis of serpiginous choroiditis.

Funder

Japan Agency for Medical Research and Development

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3